These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 16791660)
41. Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. Rodriguez A; Lisboa T; Blot S; Martin-Loeches I; Solé-Violan J; De Mendoza D; Rello J; Intensive Care Med; 2009 Mar; 35(3):430-8. PubMed ID: 19066850 [TBL] [Abstract][Full Text] [Related]
42. Decrease in drug resistance in pneumococcal community-acquired pneumonia. Obando I; Arroyo L; Sanchez-Tatay D Chest; 2007 Jul; 132(1):359; author reply 359-60. PubMed ID: 17625101 [No Abstract] [Full Text] [Related]
43. [The utility of the Pneumonia PORT prediction rule for evaluating the severity of community-acquired pneumonia in Japan. The relationship between disease severity and drug-resistant Streptococcus pneumoniae]. Nishiyama O; Taniguchi H; Kondoh Y; Kimura M; Shimizu J Kansenshogaku Zasshi; 2002 Dec; 76(12):1003-9. PubMed ID: 12607346 [TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia. Bhavnani SM; Forrest A; Hammel JP; Drusano GL; Rubino CM; Ambrose PG Diagn Microbiol Infect Dis; 2008 Sep; 62(1):99-101. PubMed ID: 18583085 [TBL] [Abstract][Full Text] [Related]
45. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia. Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596 [TBL] [Abstract][Full Text] [Related]
46. [Acute community-acquired pneumonia. A review of clinical trials]. Chidiac C Med Mal Infect; 2006; 36(11-12):650-66. PubMed ID: 16876363 [TBL] [Abstract][Full Text] [Related]
47. [Antibiotic therapy for community acquired Streptococcus pneumoniae pneumonia: clinical relevance of antibiotic resistance]. Bédos JP; Bruneel F Med Mal Infect; 2006; 36(11-12):667-79. PubMed ID: 16842956 [TBL] [Abstract][Full Text] [Related]
48. Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia. Spindler C; Ortqvist A Eur Respir J; 2006 Oct; 28(4):816-23. PubMed ID: 16737983 [TBL] [Abstract][Full Text] [Related]
49. Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: younger and more severely affected patients. Messika J; Sztrymf B; Bertrand F; Billard-Pomares T; Barnaud G; Branger C; Dreyfuss D; Ricard JD J Crit Care; 2014 Oct; 29(5):733-8. PubMed ID: 24997726 [TBL] [Abstract][Full Text] [Related]
51. Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones. Carratalá J; Martín-Herrero JE; Mykietiuk A; García-Rey C Clin Microbiol Infect; 2006 May; 12 Suppl 3():2-11. PubMed ID: 16669924 [TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R; J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376 [TBL] [Abstract][Full Text] [Related]
54. Pharmacotherapy for community-acquired pneumonia in the elderly. Viasus D; Núñez-Ramos JA; Viloria SA; Carratalà J Expert Opin Pharmacother; 2017 Jul; 18(10):957-964. PubMed ID: 28602108 [TBL] [Abstract][Full Text] [Related]
55. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Mandell LA; Bartlett JG; Dowell SF; File TM; Musher DM; Whitney C; Clin Infect Dis; 2003 Dec; 37(11):1405-33. PubMed ID: 14614663 [No Abstract] [Full Text] [Related]